These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1873659)
1. A comparison between iotrolan, a non-ionic dimer, and a hyperosmolar contrast medium, Urografin, in hysterosalpingography. Brokensha C; Whitehouse G Br J Radiol; 1991 Jul; 64(763):587-90. PubMed ID: 1873659 [TBL] [Abstract][Full Text] [Related]
2. Comparative study: Endografine (diatrizoate), Vasurix polyvidone (acetrizoate), Dimer-X (iocarmate) and Hexabrix (ioxaglate) in hysterosalpingography. Schütte HE Diagn Imaging; 1982; 51(6):277-83. PubMed ID: 7173007 [TBL] [Abstract][Full Text] [Related]
3. Comparison of patient reactions and diagnostic quality for hysterosalpingography using ionic and nonionic contrast media. Chen MY; Zagoria RJ; Fayez JA; Ott DJ; Van Swearingen FL Acad Radiol; 1995 Feb; 2(2):123-7. PubMed ID: 9419535 [TBL] [Abstract][Full Text] [Related]
4. [Experimental evaluation of iotrolan as an arthrographic contrast medium--knee arthrography with iotrolan in rabbits]. Miyazawa T; Nakagawa H Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Nov; 50(11):1381-6. PubMed ID: 2087397 [TBL] [Abstract][Full Text] [Related]
5. Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography. Lindequist S; Rasmussen F; Larsen C Radiology; 1994 May; 191(2):513-7. PubMed ID: 8153331 [TBL] [Abstract][Full Text] [Related]
6. [Hysterosalpingography using iotrolan--a new contrast medium]. Jensen HJ; Dons-Jensen H; Kamal KM Aktuelle Radiol; 1993 Sep; 3(5):292-4. PubMed ID: 8399416 [TBL] [Abstract][Full Text] [Related]
7. Comparison in myelography between iodixanol 270 and 320 mgI/ml and iotrolan 300 mgI/ml: a multicentre, randomised, parallel-group, double-blind, phase III trial. Palmers Y; Kuhn FP; Petersen D; De Greef D Eur Radiol; 2002 Mar; 12(3):686-91. PubMed ID: 11870488 [TBL] [Abstract][Full Text] [Related]
8. [Iotrolan-300 versus Iopamidol-300 in hysterosalpingography]. Schulz-Wendtland R; Bauer M; Henne KW Aktuelle Radiol; 1991 Sep; 1(5):256-8. PubMed ID: 1751562 [TBL] [Abstract][Full Text] [Related]
9. Urography with non-ionic contrast media: I. Diagnostic quality and tolerance of iohexol in comparison with meglumine amidotrizoate. Taenzer V; Heep H; Clauss W Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():148-52. PubMed ID: 6139070 [No Abstract] [Full Text] [Related]
10. [Preclinical evaluation of iotrolan as a contrast medium for angiography and urography]. Miyazawa T; Murayama C; Uchimoto R; Fritz-Zieroth B Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1287-98. PubMed ID: 1437534 [TBL] [Abstract][Full Text] [Related]
11. Ionic versus nonionic contrast media. Berlin L AJR Am J Roentgenol; 1996 Nov; 167(5):1095-7. PubMed ID: 8911157 [No Abstract] [Full Text] [Related]
12. Hexabrix as a contrast agent for hysterosalpingography. Winfield AC; Maxson WS; Harding DR; Diggs J; Wentz AC Radiology; 1984 Jul; 152(1):232-3. PubMed ID: 6729127 [TBL] [Abstract][Full Text] [Related]
13. [Iotrolan versus iopamidol. A controlled double-blind study with lumbar myelography]. Maier B; Gerber U; König M; Stetter G Radiologe; 1992 Aug; 32(8):393-6. PubMed ID: 1410326 [TBL] [Abstract][Full Text] [Related]